This page features ACC's full coverage of the latest science from Transcatheter Cardiovascular Therapeutics (TCT) 2022 – including trial summaries, news stories, journal scans, videos and more.
Nov 27, 2024 | Anthony A. Bavry, MD,MPH,FACC
The goal of the Amulet IDE trial was to evaluate left atrial appendage (LAA) occlusion with the Amulet device compared with the Watchman device among patients with nonvalvular atrial fibrillation (AF).
Oct 29, 2024 | Dharam J. Kumbhani, MD, SM, FACC
The goal of the PROTECTED TAVR trial was to evaluate the efficacy of intraprocedural cerebral embolic protection (CEP) in reducing strokes among patients undergoing transfemoral TAVR for aortic stenosis.
Dec 22, 2023 | Dharam J. Kumbhani, MD, SM, FACC
The goal of the FAME 3 trial was to demonstrate the noninferiority of fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) to coronary artery bypass grafting (CABG) for patients with three-vessel disease.
Oct 10, 2023 | Anthony A. Bavry, MD,MPH,FACC
The goal of the BYPASS-CTCA trial was to evaluate if a noninvasive computed tomography (CT) scan prior to invasive coronary angiography improves procedural outcomes in patients with prior coronary artery bypass grafting (CABG).
Jul 19, 2023 | Mirvat A. Alasnag, MBBS, FACC
Transcatheter aortic valve implantation (TAVI) is considered a safe procedure and is endorsed by the 2020 American College of Cardiology/American Heart Association (ACC/AHA) Guideline for the Management of Patients With Valvular Heart Disease for...
Jul 11, 2023 | Hooman Bakhshi, MD, FACC; M. Chadi Alraies, MD, FACC; Mohamed A. Sobhy Aly, MB, ChB, FACC
The BEST (Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients with Multivessel Coronary Artery Disease) trial was designed to compare the cardiovascular outcomes in...
Jan 23, 2023 | Louai Razzouk, MD, FACC; Sunil V. Rao, MD, FACC
In this expert analysis we present information regarding three trials related to vascular medicine presented at the 2022 Transcatheter Cardiovascular Therapeutics (TCT) Scientific Sessions held in Boston, Massachusetts, September 16-19.
Oct 28, 2022
A lot of science related to coronary and structural interventions was delivered at TCT 2022, back in person and held in Boston. And there were several trials that offer new therapies and practice-changing insights for patients with advanced...
Oct 28, 2022
Featured topics and Editors' Picks from all of ACC's JACC Journals.
Sep 26, 2022 | Anthony A. Bavry, MD,MPH,FACC
The goal of the COPS trial was to evaluate cutting balloon angioplasty compared with noncompliant balloon angioplasty among patients with severe coronary artery calcium undergoing percutaneous coronary intervention (PCI).
Log in to MyACC